Showing results (631-640 of 1,351) with videos related to
Sort By:
Pageof 136
Clinical Pharmacology in Drug Development|March 23, 2026
Pharmacokinetics and Bioequivalence of 2 Deutetrabenazine Tablets in Healthy Chinese Volunteers Under Fasting and Fed ConditionsDayong Xu, Pengkai Wang, Yuan Li, et al.Clinical Pharmacology in Drug Development|April 30, 2026
A Phase 1, Open-Label, Single-Dose Study of the Effect of Hepatic Impairment on the Pharmacokinetics of Erdafitinib, an FGFR InhibitorWei Zhu, Peter Hellemans, Anna Mitselos, et al.Clinical Pharmacology in Drug Development|April 8, 2026
Steady-State Pharmacokinetic Properties of TNX-102 SL, a Sublingual Tablet Formulation of Cyclobenzaprine Hydrochloride (HCl), With Daily Dosing in Healthy Volunteers: A Randomized, Open-Label TrialGregory M Sullivan, Bernd Meibohm, Errol Gould, et al.Clinical Pharmacology in Drug Development|July 2, 2026
Comparison of ABBV-552 Safety and Pharmacokinetics in Healthy Asian and Western AdultsNick Miles, Brian McNamee, Cindy Zadikoff, et al.Clinical Pharmacology in Drug Development|June 19, 2026
Bioequivalence of a Fixed-Dose Combination of Relugolix, Estradiol, and Norethindrone Acetate: An Open-Label, Randomized, Fully Replicate Crossover Study in Healthy Postmenopausal Women Under Fasting ConditionsRavi Kotadia, Sudershan Kumar, Arshad Khuroo, et al.Clinical Pharmacology in Drug Development|July 20, 2026
Pharmacokinetics and Bioequivalence of Tamsulosin Hydrochloride Extended-Release Capsules in Healthy Chinese Volunteers: A Randomized, Open-Label, Crossover Study Under Fasting and Fed ConditionsLijie Du, Xiaolu Wang, Yi Zhang, et al.Clinical Pharmacology in Drug Development|October 9, 2026
Population Pharmacokinetics and Exposure-Response Analysis of Arpraziquantel Supporting Dose in Preschool-Aged Children Infected with SchistosomaBrigitte Brockhaus, Richard Mills, Ana-Marija Milenković-Grišić, et al.Clinical Pharmacology in Drug Development|October 15, 2026
Formulation-Dependent Modulation of Ibuprofen Absorption Kinetics in Fixed-Dose Combinations: An Exploratory Analysis of the Dissolution-Absorption RelationshipSatoko Ueda, Mitsuaki Chujo, Nobuo Miyadai, et al.Clinical Pharmacology in Drug Development|October 24, 2026
Safety, Tolerability, and Pharmacokinetics of EGT710, a Novel Coronavirus Mpro Inhibitor, in Healthy Adults: A Randomized, Single- and Multiple-Dose StudyJart A F Oosterhaven, Jonathan Trolander, Lidiya Bebrevska, et al.Clinical Pharmacology in Drug Development|November 23, 2021
Evaluation of the Pharmacokinetic Interaction and Safety of Ubrogepant Coadministered With Esomeprazole MagnesiumRamesh Boinpally, Kaifeng LuPageof 136